demonstrated that daily H 2 S treatment can reduce the histopathological markers of renal injury following 30 days of unilateral ureteral obstruction (UUO). The current study employs UUO followed by reimplantation to investigate the effects of daily H 2 S on renal function following the relief of obstruction.
METHODS: The left ureter of male Lewis rats were ligated at the ureterovesical junction. Starting on post-operative day (POD) 1 and every day for 13 days, rats received either daily intraperitoneal (IP) injection of phosphate buffered saline (PBS) vehicle or 200mmol/kg of GYY4137 (slow-releasing H 2 S donor) in PBS. On POD 14, the ligature was removed and the left ureter was reimplanted into the bladder, and a right nephrectomy performed so that the rat is solely dependent on the left kidney. Urine and serum samples were collected to monitor renal function. On POD 30, the left kidney was removed and tissue sections were stained with hematoxylin and eosin (H&E) to measure cortical thickness.
RESULTS: 67% of control rats, compared to 100% of H 2 Streated rats, lived until POD 30. Histological analysis showed a significant decrease in cortical thickness (P<0.0001) in control rats when compared to Sham rats, which was significantly rescued upon treatment with H 2 S (P<0.0001). Serum creatinine (SCr) in control rats, but not H 2 S-treated rats, was significantly increased when compared to Sham animals on POD 3 and 7 (P<0.05). Following reimplantation (PODs 17, 21, 24 and 30), SCr in both control and treatment groups were significantly elevated when compared to Sham. Interestingly, H 2 S treatment drastically decreased SCr levels when compared to control animals on all PODs after reimplantation. Proteinuria continued to be higher in both control and treatment groups following reimplantation compared to Sham (P<0.05), however, H 2 S treatment group showed markedly reduced proteinuria compared to the control group.
CONCLUSIONS: We show, for the first time, that daily H 2 S therapy rescues renal function and preserves renal architecture following UO. H 2 S may one day become a clinically viable pre-emptive therapy against renal injury associated with UO and contribute to improved renal function in patients with UO.
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MP19-10 IDENTIFICATION OF NEW URINARY RISK MARKERS FOR URINARY STONE PATIENTS USING LOGISTIC MODEL AND MULTINOMIAL-LOGIT MODEL
Atsushi Okada*, Teruaki Sugino, Rei Unno, Kazumi Taguchi, Shuzo Hamamoto, Ryosuke Ando, Keiichi Tozawa, Takahiro Yasui, Nagoya, Japan INTRODUCTION AND OBJECTIVES: The risk assessment of urinary stone disease so far has been conducted mainly on urinary biochemistry, but it has not been fully utilized for prevention of recurrence. We have clarified that inflammation is involved in the formation process of calcium oxalate (CaOx) stones. In this study, we tried to extract new stone risk factors by statistically analyzing urinary biochemistry and urine inflammation related factors.
METHODS: The subjects were male (20-79 years old) who visited Nagoya City University Hospital, excluding patients with history of abnormal urinalysis, history of tumor and collagen disease, patients taking immunosuppressants and steroids, and divided into two groups, normal group (48 cases) without history of stone and stone group who experienced CaOx stone (22 cases of the first time group, 40 cases of recurrence).
RESULTS: Comparison between the normal group and the first time group revealed that the areas under the curve (AUC) of ROC of IL1a and IL-4 as independent factors were significantly high (1.00 and 0.87 (P <0.01 in each case), respectively), which suggested that the two factors were specific to first time patients. In the comparison between the normal group and the stone group, the AUC value increased to 0.87, 0.86 by combining IL-1a or IL-4 with GM-CSF and IL-1b (both P <0.01) respectively, and the values were not as high as the discrimination between the normal and the first time groups. In the comparison of the three groups (normal, first time and recurrence group), discrimination ability by multinomial logit model using IL-4, GM-CSF, IL-1b and IL-10 including urinary Mg was the highest (prediction accuracy: 82.6%).
CONCLUSIONS: IL-4, IL-1a, GM-CSF, IL-1b and IL-10 were identified as urinary inflammation related factors that can accurately distinguish normal subjects and urinary stone patients. These factors are related to the activity of macrophages and neutrophils and it was suggested that combining with urinary biochemistry data could be an index to more clearly evaluate the risk of urinary stone formation.
Source of Funding: None
MP19-11 SYSTEMIC BIOMINERALIZATION IN KIDNEY STONE FORMERS
Benjamin Sherer*, Sunita Ho, Marshall Stoller, San Francisco, CA INTRODUCTION AND OBJECTIVES: Emerging data has revealed that patients with nephrolithiasis are at increased risk for atherosclerosis, coronary artery disease, and stroke. While nephrolithiasis occurs within a broad spectrum of human pathologic biomineralization, the overall association of nephrolithiasis with mineralization processes at non-renal, non-osseous sites is poorly understood. The objective of this study is to characterize the overall burden of systemic biomineralization in known kidney stone formers (SFs) compared to non stone formers (NSFs).
METHODS: The presence and quantity of biomineralization at 9 non-renal anatomic locations (listed in results) was determined by a blinded, retrospective review of clinical non-contrast computed tomography (CT) scans of the abdomen/pelvis in known SFs (n ¼ 71, mean age 52.3) and were compared to an age-matched control group of NSFs (renal transplant donors, n¼86, mean age 51.6). Each anatomic site of interest was assigned a mineralization score based on calculated CT volume of visible calcification (0 ¼ none)( 1 ¼ less than 0.5cm^3) ( 2 ¼ 0.5cm3 to 1.0cm^3)( 3 ¼ greater than 1.0cm^3). Patients were also evaluated for age, gender, BMI, comorbidities, and stone type.
RESULTS: The average systemic mineralization score was significantly higher in stone formers (4.14) compared to controls (2.16). SFs were more likely than NSFs to have mineral densities in the heart (19.7% vs 3.4%), aorta (46.5% vs 23.2%), iliac arteries (38.0% vs 14.0%),spleen/splenic artery (8.95% vs 4.7%), mesentery (15.5% vs 4.7%), uterus (48.34% vs 46.7%), prostate (62.2% vs 24.0%), and pancreas (8.45% vs 0.0%). The presence of pelvic phleboliths was similar in both groups (62.0% vs 62.8%). Site-specific mineralization scores were higher in SFs at all anatomic sites (Fig 1) . SFs also had higher degree of obesity (BMI 29.73 vs 27.8) and higher rates of comorbidities including diabetes, hypertension, and hyperlipidemia.
CONCLUSIONS: SFs have increased mineralization at many anatomic sites compared to NSFs. Understanding nephrolithiasis within the context of systemic biomineralization may help to better elucidate underlying mechanisms of nephrolithiasis and other pathologic biomineralization processes.
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